z-logo
open-access-imgOpen Access
Effects of Atorvastatin on Resting and Peak Exercise Blood Pressure among Normotensive Men and Women
Author(s) -
Amanda L. Zaleski,
Marianne L. Mentch,
Linda S. Pescatello,
Beth A. Taylor,
Jeffrey A. Capizzi,
Adam Grimaldi,
Priscilla M. Clarkson,
Stephanie MoeckelCole,
Stuart R. Chipkin,
Justin Keadle,
C Michael White,
Paul M. Thompson
Publication year - 2014
Publication title -
cholesterol
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.876
H-Index - 20
eISSN - 2090-1291
pISSN - 2090-1283
DOI - 10.1155/2014/720507
Subject(s) - atorvastatin , medicine , blood pressure , placebo , diastole , cardiology , endocrinology , alternative medicine , pathology
Statins are the most widely prescribed and effective medication for reducing low density lipoprotein cholesterol. Statins may also lower resting blood pressure (BP); however, results are inconsistent. We sought to determine if the maximum dose of atorvastatin reduces resting BP and the peak systolic BP (SBP) achieved on a graded exercise stress test (GEST) among a large sample of 419 healthy men (48%) and women (52%). Subjects (419, 44.1 ± 0.8 yr) were double-blinded and randomized to 80 mg·d −1 of atorvastatin ( n = 202) or placebo ( n = 217) for 6 mo. Among the total sample, there were no differences in resting BP (SBP, P = 0.30; diastolic BP [DBP], P = 0.69; mean arterial pressure ( P = 0.76); or peak SBP on a GEST ( P = 0.99)) over 6 mo, regardless of drug treatment group. However, among women on atorvastatin, resting SBP/DBP (3.7±1.5 mmHg, P = 0.01/3.2±0.9 mmHg, P = 0.02) and peak SBP on a GEST (6.5±1.5 mmHg, P = 0.04) were lower versus men. Atorvastatin lowered resting BP 3-4 mmHg and peak SBP on a GEST ~7 mmHg more among women than men over 6 mo of treatment. The inconsistent findings regarding the antihypertensive effects of statins may be partially explained by not accounting for sex effects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom